Vir Biotechnology (VIR) Current Taxes (2021 - 2023)

Vir Biotechnology's Current Taxes history runs 3 years deep, the most recent figure standing at $15.3 million for Q1 2023.

• In Q1 2023, Current Taxes fell 96.23% year-over-year to $15.3 million; the TTM figure through Mar 2023 stood at $15.3 million (down 96.23% YoY), while the FY2022 annual figure was $15.2 million, up 144.94% from the prior year.
• Current Taxes came in at $15.3 million for Q1 2023 at Vir Biotechnology, roughly flat from $15.2 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $404.4 million in Q1 2022 to a low of $6.2 million in Q4 2021.
• A 3-year average of $116.1 million and a median of $56.7 million in 2022 frame the typical range for Current Taxes.
• Across the five-year window, Current Taxes soared 144.94% in 2022 and slumped 96.23% in 2023, its largest moves.
• Vir Biotechnology's Current Taxes stood at $6.2 million in 2021, then soared by 144.94% to $15.2 million in 2022, then rose by 0.16% to $15.3 million in 2023.
• According to Business Quant data, Current Taxes over the past three periods registered $15.3 million, $15.2 million, and $98.2 million for Q1 2023, Q4 2022, and Q3 2022 respectively.

Peer Comparison